BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34488438)

  • 1. Epidemiologic and Genetic Associations of Erythropoietin With Blood Pressure, Hypertension, and Coronary Artery Disease.
    Sun P; Kumar N; Tin A; Zhao J; Brown MR; Lin Z; Yang ML; Zheng Q; Jia J; Bielak LF; Yu B; Boerwinkle E; Hunker KL; Coresh J; Chen YE; Huo Y; Kardia SLR; Khoriaty R; Zhou X; Morrison AC; Zhang Y; Ganesh SK
    Hypertension; 2021 Nov; 78(5):1555-1566. PubMed ID: 34488438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human urotensin II as a link between hypertension and coronary artery disease.
    Watanabe T; Kanome T; Miyazaki A; Katagiri T
    Hypertens Res; 2006 Jun; 29(6):375-87. PubMed ID: 16940699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia.
    Weissmann N; Manz D; Buchspies D; Keller S; Mehling T; Voswinckel R; Quanz K; Ghofrani HA; Schermuly RT; Fink L; Seeger W; Gassmann M; Grimminger F
    Thromb Haemost; 2005 Sep; 94(3):630-8. PubMed ID: 16268482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension?
    Langenfeld MR; Veelken R; Schobel HP; Friedrich A; Schmieder RE
    Nephrol Dial Transplant; 1997 Jun; 12(6):1155-60. PubMed ID: 9198044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum chloride is an independent risk factor for coronary heart disease: A retrospective study of more than 13,000 Han Chinese.
    Zhao Y; Liu M; Wang X; Chen S; Zhou M; Li Q; Li S; Huang Y; Zhao L; Wang Q; Tu X
    Int J Cardiol; 2015 Nov; 198():61-2. PubMed ID: 26151716
    [No Abstract]   [Full Text] [Related]  

  • 6. Endogenous erythropoietin correlates with blood pressure in essential hypertension.
    Schmieder RE; Langenfeld MR; Hilgers KF
    Am J Kidney Dis; 1997 Mar; 29(3):376-82. PubMed ID: 9041213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uric acid and ischemic cardiopathy].
    de Castro JJ
    Rev Port Cardiol; 1988; 7(3):347-9. PubMed ID: 3078733
    [No Abstract]   [Full Text] [Related]  

  • 8. Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study.
    De Luca G; Secco GG; Santagostino M; Venegoni L; Iorio S; Cassetti E; Verdoia M; Coppo L; Di Mario C; Bellomo G; Marino P;
    Nutr Metab Cardiovasc Dis; 2012 May; 22(5):426-33. PubMed ID: 21186110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between red cell distribution width, erythropoietin levels, and coronary artery disease.
    Li Y; Li M; Teng Y; Zhang C; Liu Q; Hou H
    Coron Artery Dis; 2018 Jan; 29(1):74-80. PubMed ID: 28885393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition to higher blood pressure increases coronary artery disease risk.
    Lieb W; Jansen H; Loley C; Pencina MJ; Nelson CP; Newton-Cheh C; Kathiresan S; Reilly MP; Assimes TL; Boerwinkle E; Hall AS; Hengstenberg C; Laaksonen R; McPherson R; Thorsteinsdottir U; Ziegler A; Peters A; Thompson JR; König IR; Erdmann J; Samani NJ; Vasan RS; Schunkert H;
    Hypertension; 2013 May; 61(5):995-1001. PubMed ID: 23478099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis.
    Zhang Y; Wang Y; Zhang L; Xia L; Zheng M; Zeng Z; Liu Y; Yarovinsky T; Ostriker AC; Fan X; Weng K; Su M; Huang P; Martin KA; Hwa J; Tang WH
    Circ Res; 2020 Sep; 127(7):855-873. PubMed ID: 32597702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to cardiolipin and beta-2-glycoprotein-I in coronary artery disease patients with and without hypertension.
    Sherer Y; Tenenbaum A; Praprotnik S; Shemesh J; Blank M; Fisman EZ; Motro M; Shoenfeld Y
    Cardiology; 2002; 97(1):2-5. PubMed ID: 11893822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease--the ENCORE Trials.
    Hermann M; Hellermann JP; Quitzau K; Hoffmann MM; Gasser T; Meinertz T; Münzel T; Fleming I; Lüscher TF
    Atherosclerosis; 2009 Dec; 207(2):476-9. PubMed ID: 19615687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensively lowering both low-density lipoprotein cholesterol and blood pressure does not reduce cardiovascular risk in Japanese coronary artery disease patients.
    Kohro T; Yamazaki T; Izumi T; Daida H; Kurabayashi M; Miyauchi K; Tojo T; Nagai R;
    Circ J; 2011; 75(9):2062-70. PubMed ID: 21817806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies.
    Wong TY; Larsen EK; Klein R; Mitchell P; Couper DJ; Klein BE; Hubbard LD; Siscovick DS; Sharrett AR
    Ophthalmology; 2005 Apr; 112(4):540-7. PubMed ID: 15808241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-selectin and C-reactive protein in relation to home blood pressure and coronary calcification: a SCAPIS substudy.
    Af Geijerstam P; Rådholm K; Jonasson L; Lindahl TL; Engvall J; Nyström FH; Alfredsson J
    J Hypertens; 2024 Jul; 42(7):1226-1234. PubMed ID: 38690927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of erythropoietin in cortisol-induced hypertension.
    Kelly JJ; Martin A; Whitworth JA
    J Hum Hypertens; 2000 Mar; 14(3):195-8. PubMed ID: 10694834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice.
    Frýdlová J; Rychtarčíková Z; Gurieva I; Vokurka M; Truksa J; Krijt J
    PLoS One; 2017; 12(10):e0186844. PubMed ID: 29073189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS3pt-/- ).
    Kubis N; Richer C; Domergue V; Giudicelli JF; Lévy BI
    J Hypertens; 2002 Aug; 20(8):1581-7. PubMed ID: 12172320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study.
    Nikpour M; Urowitz MB; Ibanez D; Harvey PJ; Gladman DD
    Arthritis Res Ther; 2011; 13(5):R156. PubMed ID: 21955652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.